Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
TEVA-ERLOTINIB | 150MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176830 |
TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176833 |
TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2022-12-01 | 2023-02-16 | 176842 |
TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176845 |
TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176857 |
PORTIA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177502 |
PORTIA 28 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177505 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177508 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177511 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-02-02 | 177514 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177517 |
TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-12-08 | 2023-01-26 | 177520 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-12-08 | 2023-04-28 | 177523 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-12-08 | 2023-06-09 | 177526 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-12-08 | 2023-01-19 | 177529 |
TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2022-12-08 | 2022-12-15 | 177532 |
ZADITEN | 1MG | TABLET | Resolved | 2022-12-08 | 2023-04-15 | 177535 |
ACT AMLODIPINE | 5MG | TABLET | Resolved | 2022-12-15 | 2023-02-16 | 178518 |
ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-12-15 | 2023-04-28 | 178521 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |